Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity

Journal of Hepatology

Volumn 26, Issue 2, 1997, Pages 280-286

  Douds, Andrew C ^a   Lim, A Guan ^a   Jazrawi, Riadh P ^a   Finlayson, Caroline ^a   Maxwell, J Douglas ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

alcoholic liver disease; cell mediated immunity; ELISA; inflammation; neopterin; RIA; soluble intercellular adhesion molecule 1; soluble interleukin 2 receptor; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; INFLAMMATION; LIVER BIOPSY; MALE; OUTPATIENT; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031039603     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80042-6     Document Type: Article

References (22)

1. Springer TA. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
2. Marlin SD, Springer TA. Purified intercellular adhesion molecule (ICAM-1) is a ligand for lymphocyte function associated antigen-1 (LFA-1). Cell. 51:1987;813-819.
3. Rothlein R, Mainolfi E, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol. 147:1991;3788-3793.
4. Simpson KJ, Hayes PC. Soluble adhesion molecules in immune mediated liver disease. Gut. 36:1995;806-808.
5. Burra P, Hubscher SG, Shaw J, Elias E, Adams DH. Is the intercellular adhesion molecule-1/leukocyte function associated antigen-1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? Gut. 33:1992;268-271.
6. Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias E, Rothlein R. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology. 16:1992;810-814.
7. Shimada S, Yamauchi M, Toda G. Serum levels of intercellular adhesion molecule-1 in patients with alcoholic liver disease. Alcohol Alcoholism. 28:1993;47-51. (SIB).
8. Mandi Y, Nagy I. Circulating ICAM-1 in alcoholic liver cirrhosis. Int Arch Allergy Immunol. 106:1995;302-304.
9. Alcoholic liver disease: morphological manifestations. Lancet. 1:1981;707-711.
10. Nyberg A, Loof L, Hallgren R. Serum beta 2-microglobulin levels in primary biliary cirrhosis. Hepatology. 5:1985;282-285.
11. Muller C, Knoflach P, Zielinski CC. Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease. Hepatology. 10:1989;928-932.
12. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today. 9:1988;150-155.
13. Lim AG, Jazrawi RP, Ahmed HA, Levy JH, Zuin M, Douds AC, Maxwell JD, Northfield TC. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis. Hepatology. 20:1994;882-888.
14. Nouri-Aria KT, Koskinas J, Tibbs CJ, Portmann BC, Williams R. Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon alpha. Gut. 36:1995;599-603.
15. Zohrens G, Armbrust T, Pirzer U, Meyer Zum Buschenfelde KH, Ramadori G. Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology. 18:1993;798-802.
16. Simpson KJ, Jones AL, Forbes Howie A, Hayes PC. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic active hepatitis. Eur J Gasroenterol Hepatol. 7:1995;455-460.
17. Hislop WS, Bouchier IAD, Allan JG, Brunt PW, Eastwood M, Finlayson NDC, James O, Russell RI, Watkinson G. Alcoholic liver disease in Scotland and Northeastern England: Presenting features in 510 patients. Quart J Med. 206:1983;232-243.
18. French SW, Burridge EJ. Alcoholic hepatitis: clinical, morphological and therapeutic agents. Popper H, Schaffner F. Progress in Liver Disease. VI:1979;557-580 Grune and Stratton, New York.
19. Ohira H, Ueno T, Shakado S. Cultured rat hepatic sinusoidal endothelial cells express intercellular adhesion molecule-1 (ICAM-1) by tumour necrosis factor-α or interleukin-1α stimulation. J Hepatol. 20:1994;729-734.
20. Morita M, Watanabe Y, Akaike T. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology. 19:1994;426-431.
21. Thomson AW, Satoh S, Nussler AK, Tamura K, Woo J, Gavaler J, Van Thiel DH. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-simulated hepatocytes. Clin Exp Immunol. 95:1994;83-90.
22. Gearing AJH, Hemingway I, Piggott R, Hughes J, Rees AJ, Cashmen SJ. Soluble forms of vascular adhesion molecules, ICAM-1 and VCAM-1: pathological significance. Ann NY Acad Sci. 667:1992;324-331.